To our knowledge, this study represents the first demonstration of elevated GBA1 (p = 0.014) and UGCG (p = 0.0002) mRNA expression levels in patients experiencing a current MDE compared to patients with remitted MDD and healthy controls. This evidence concerns the gene GBA1 and major depressive disorder.